BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 21296443)

  • 21. Point/Counterpoint: PET-based GTV definition is the future of radiotherapy treatment planning.
    Ahmad S; Devic S; Orton CG
    Med Phys; 2012 Oct; 39(10):5791-4. PubMed ID: 23039618
    [No Abstract]   [Full Text] [Related]  

  • 22. Introduction: metabolic and functional imaging in radiation therapy.
    Balter J
    Semin Radiat Oncol; 2011 Apr; 21(2):79. PubMed ID: 21356475
    [No Abstract]   [Full Text] [Related]  

  • 23. Point/counterpoint. Respiratory gating for radiation therapy is not ready for prime time.
    Li XA; Keall PJ; Orton CG
    Med Phys; 2007 Mar; 34(3):867-70. PubMed ID: 17441231
    [No Abstract]   [Full Text] [Related]  

  • 24. Dosimetry in nuclear medicine therapy.
    Chiesa C; Lassmann M
    Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):2-4. PubMed ID: 21386781
    [No Abstract]   [Full Text] [Related]  

  • 25. The importance of dosimetry in nuclear medicine therapy practice.
    Bisi G
    Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):1. PubMed ID: 21386780
    [No Abstract]   [Full Text] [Related]  

  • 26. [A 3D MLE algorithm for positron emission tomography during radiotherapy with heavy ions].
    Lauckner K; Enghardt W; Hinz R; Freyer R
    Biomed Tech (Berl); 1998; 43 Suppl():28-9. PubMed ID: 9859241
    [No Abstract]   [Full Text] [Related]  

  • 27. Recommendations on how to establish evidence from auto-segmentation software in radiotherapy.
    Valentini V; Boldrini L; Damiani A; Muren LP
    Radiother Oncol; 2014 Sep; 112(3):317-20. PubMed ID: 25315862
    [No Abstract]   [Full Text] [Related]  

  • 28. Compensability index for compensation radiotherapy after treatment interruptions.
    Putora PM; Schmuecking M; Aebersold D; Plasswilm L
    Radiat Oncol; 2012 Dec; 7():208. PubMed ID: 23216952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Within the next five years, most radiotherapy treatment schedules will be designed using spatiotemporal optimization.
    Kim M; Craft DL
    Med Phys; 2016 May; 43(5):2009. PubMed ID: 27147312
    [No Abstract]   [Full Text] [Related]  

  • 30. Is it possible to optimize a radiotherapy treatment plan?
    Rowbottom CG; Webb S; Oldham M
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):698-9. PubMed ID: 10078659
    [No Abstract]   [Full Text] [Related]  

  • 31. Comments on 'Standard effective doses for proliferative tumours'.
    Daşu IL; Daşu A; Denekamp J; Fowler JF
    Phys Med Biol; 2000 Oct; 45(10):L45-50. PubMed ID: 11049194
    [No Abstract]   [Full Text] [Related]  

  • 32. Crowd knowledge based community in radiotherapy: in response to Yartev et al.
    Mancosu P; Baroni G; Alongi F; Esposito L; Stasi M; Strigari L
    Radiother Oncol; 2014 Sep; 112(3):453. PubMed ID: 24951016
    [No Abstract]   [Full Text] [Related]  

  • 33. Recommissioning of treatment planning software.
    Mott D
    Br J Radiol; 1997 Mar; 70():319-20. PubMed ID: 9166064
    [No Abstract]   [Full Text] [Related]  

  • 34. Lung cancer. Radiotherapy in lung cancer: Actual methods and future trends.
    Maciejczyk A; Skrzypczyńska I; Janiszewska M
    Rep Pract Oncol Radiother; 2014 Nov; 19(6):353-60. PubMed ID: 25337407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 11C-Choline PET/pathology image coregistration in primary localized prostate cancer.
    Grosu AL; Weirich G; Wendl C; Prokic V; Kirste S; Geinitz H; Souvatzoglou M; Gschwend JE; Schwaiger M; Molls M; Weber WA; Treiber U; Krause BJ
    Eur J Nucl Med Mol Imaging; 2014 Dec; 41(12):2242-8. PubMed ID: 25186430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges and opportunities in patient-specific, motion-managed and PET/CT-guided radiation therapy of lung cancer: review and perspective.
    Bowen SR; Nyflot MJ; Gensheimer M; Hendrickson KR; Kinahan PE; Sandison GA; Patel SA
    Clin Transl Med; 2012 Aug; 1(1):18. PubMed ID: 23369522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the SUV values calculation and 4D PET integration in the radiotherapy treatment planning system.
    Jacob V; Astner ST; Bundschuh RA; Busch R; Souvatzoglou M; Wendl C; Kneschaurek P; Grosu AL
    Radiother Oncol; 2011 Mar; 98(3):323-9. PubMed ID: 21296443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical radiotherapy treatment planning based on functional PET/CT data.
    Thorwarth D; Geets X; Paiusco M
    Radiother Oncol; 2010 Sep; 96(3):317-24. PubMed ID: 20673689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET/CT (and CT) instrumentation, image reconstruction and data transfer for radiotherapy planning.
    Sattler B; Lee JA; Lonsdale M; Coche E
    Radiother Oncol; 2010 Sep; 96(3):288-97. PubMed ID: 20709416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric verification and clinical evaluation of a new commercially available Monte Carlo-based dose algorithm for application in stereotactic body radiation therapy (SBRT) treatment planning.
    Fragoso M; Wen N; Kumar S; Liu D; Ryu S; Movsas B; Munther A; Chetty IJ
    Phys Med Biol; 2010 Aug; 55(16):4445-64. PubMed ID: 20668343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.